M
Marco Del Chiaro
Researcher at Anschutz Medical Campus
Publications - 224
Citations - 9245
Marco Del Chiaro is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Pancreatic cancer & Medicine. The author has an hindex of 35, co-authored 173 publications receiving 6273 citations. Previous affiliations of Marco Del Chiaro include University of Colorado Boulder & University of Colorado Denver.
Papers
More filters
Journal ArticleDOI
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After
Claudio Bassi,Giovanni Marchegiani,Christos Dervenis,Sarr Mg,Mohammad Abu Hilal,Mustapha Adam,Peter J. Allen,Roland Andersson,Horacio J. Asbun,Marc G. Besselink,Kevin C. Conlon,Marco Del Chiaro,Massimo Falconi,Laureano Fernández-Cruz,Carlos Fernandez-del Castillo,Abe Fingerhut,Helmut Friess,Dirk J. Gouma,Thilo Hackert,Jakob R. Izbicki,Keith D. Lillemoe,John P. Neoptolemos,Attila Oláh,Richard D. Schulick,Shailesh V. Shrikhande,Tadahiro Takada,Kyoichi Takaori,William Traverso,C. Vollmer,Christopher L. Wolfgang,Charles J. Yeo,Roberto Salvia,M.W. Büchler +32 more
TL;DR: This new definition and grading system of postoperative pancreatic Fistula should lead to a more universally consistent evaluation of operative outcomes after pancreatic operation and will allow for a better comparison of techniques used to mitigate the rate and clinical impact of a pancreatic fistula.
Journal ArticleDOI
European evidence-based guidelines on pancreatic cystic neoplasms
Marco Del Chiaro,Marc G. Besselink,Lianne Scholten,Marco J. Bruno,Djuna L. Cahen,Thomas M. Gress,Jeanin E. van Hooft,Markus M. Lerch,Julia Mayerle,Thilo Hackert,Sohei Satoi,Alessandro Zerbi,David Cunningham,Claudio De Angelis,Marc Giovanni,Enrique de-Madaria,Péter Hegyi,Jonas Rosendahl,Helmut Friess,Riccardo Manfredi,Philippe Lévy,Francisco X. Real,Alain Sauvanet,Mohammed Abu Hilal,Giovanni Marchegiani,Irene Esposito,Paula Ghaneh,Marc R. W. Engelbrecht,Paul Fockens,Nadine C.M. van Huijgevoort,Christopher L. Wolfgang,Claudio Bassi,Natalya Gubergrits,Caroline S. Verbeke,Günter Klöppel,Aldo Scarpa,Giuseppe Zamboni,Anne Marie Lennon,Malin Sund,Nikolaos Kartalis,Lars Grenacher,Massimo Falconi,Urban Arnelo,Kostantin V. Kopchak,Kofi Oppong,Colin J. McKay,Truls Hauge,Kevin C. Conlon,Mustapha Adham,Güralp O. Ceyhan,Roberto Salvia,Christos Dervenis,Peter J. Allen,François Paye,Detlef K. Bartsch,Matthias Löhr,Massimiliano Mutignani,Johanna Laukkarinen,Richard D. Schulick,Roberto Valente,Thomas Seufferlein,Gabriele Capurso,Ajith K. Siriwardena,John P. Neoptolemos,Aldis Pukitis,Ralf Segersvärd,Ali A. Aghdassi,Stefano Andrianello,Peter Bossuyt,Robin Bülow,Karina Cárdenas-Jaén,P. Cortegoso,Martina Fontana,Lena Haeberle,M. Heckler,Andrey Litvin,Kulbir Mann,Christoph W. Michalski,Patrick Michl,Gennaro Nappo,Giampaolo Perri,S. Persson,F. Scheufele,Francesco Sclafani,Manuel Schmidt,L. Venezia,F. Volker,M-P Vullierm,L. Wusten +88 more
TL;DR: A conservative approach is recommended for asymptomatic MCN and IPMN, and Lifelong follow-up of IPMN is recommended in patients who are fit for surgery.
Journal ArticleDOI
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti,Niccola Funel,Godefridus J. Peters,Marco Del Chiaro,Leyla A. Erozenci,Enrico Vasile,Leticia G. Leon,Luca Pollina,Annemieke Groen,Alfredo Falcone,Romano Danesi,Daniela Campani,Henk M.W. Verheul,Ugo Boggi +13 more
TL;DR: Modulation of apoptosis, Akt phosphorylation, and expression of genes involved in invasive behavior may contribute to the role of miR-21 in gemcitabine chemoresistance and to the rational development of new targeted combinations.
Journal ArticleDOI
European experts consensus statement on cystic tumours of the pancreas.
Marco Del Chiaro,Caroline S. Verbeke,Roberto Salvia,Günter Klöppel,Jens Werner,Colin J. McKay,Helmut Friess,Riccardo Manfredi,Eric Van Cutsem,Matthias Löhr,Ralf Segersvärd,L. Abakken,Mustapha Adham,N. Albin,Å. Andrén-Sandberg,Urban Arnelo,Marco J. Bruno,Djuna L. Cahen,Carla Cappelli,Guido Costamagna,M Del Chiaro,G. Delle Fave,Irene Esposito,Massimo Falconi,Helmut Friess,Paula Ghaneh,I. P. Gladhaug,Stephan L. Haas,Truls Hauge,Jakob R. Izbicki,Günther Klöppel,Markus M. Lerch,Lars Lundell,Jutta Lüttges,M. Löhr,R. Manfredi,Julia Mayerle,C. McKay,Kofi Oppong,Aldis Pukitis,Elena Rangelova,Thomas Rösch,Roberto Salvia,Richard D. Schulick,R. Segersvärd,T. Sufferlein,E. Van Cutsem,S. van der Merwe,C. Verbeke,J. Werner,Giuseppe Zamboni +50 more
TL;DR: Diagnostic computerized tomography and/or magnetic resonance imaging are indicated in all patients with cystic lesion of the pancreas and in lesions with a suspicion of malignancy, otherwise organ preserving procedures may be considered.
Journal ArticleDOI
Pancreatic adenocarcinoma, Version 2.2021
Margaret A. Tempero,Mokenge P. Malafa,Mahmoud M. Al-Hawary,Stephen W. Behrman,Al B. Benson,Dana Backlund Cardin,E. Gabriela Chiorean,Vincent Chung,Brian G. Czito,Marco Del Chiaro,Mary Dillhoff,Timothy R. Donahue,Efrat Dotan,Cristina R. Ferrone,Christos Fountzilas,Jeffrey M. Hardacre,William G. Hawkins,Kelsey Klute,Andrew H. Ko,John W. Kunstman,Noelle K. LoConte,Andrew M. Lowy,Cassadie Moravek,Eric K. Nakakura,Amol Narang,Jorge Obando,Patricio M. Polanco,Sushanth Reddy,Marsha Reyngold,Courtney L. Scaife,Jeanne Shen,Charles M. Vollmer,Robert A. Wolff,Brian M. Wolpin,Beth Lynn,Giby V. George +35 more
Abstract: Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pancreatic cancer. Although survival rates remain relatively unchanged, newer modalities of treatment, including targeted therapies, provide hope for improving patient outcomes. Sections of the manuscript have been updated to be concordant with the most recent update to the guidelines. This manuscript focuses on the available systemic therapy approaches, specifically the treatment options for locally advanced and metastatic disease.